• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alector, Inc. - Common Stock (NQ:ALEC)

1.860 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Alector, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer
December 12, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Participate in the Bank of America CNS Therapeutics Conference
December 01, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm
November 26, 2025
From Schall Law
Via GlobeNewswire
News headline image
ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm
November 19, 2025
From Schall Law
Via GlobeNewswire
News headline image
ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm
November 11, 2025
From The Schall Law Firm
Via Business Wire
News headline image
Alector Reports Third Quarter 2025 Financial Results and Provides Business Update
November 06, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update
October 21, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Host Virtual Research and Development Event Highlighting PGRN Franchise and Brain Carrier Programs
September 16, 2025
--Agenda to feature latozinemab and AL101, along with progress in Alector Brain Carrier–enabled programs, including new lead candidates-- 
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Participate in Upcoming Healthcare Conferences
August 28, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports Second Quarter 2025 Financial Results and Provides Business Update
August 07, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call
July 31, 2025
Call Scheduled for Thursday, August 7, 2025, at 4:30 p.m. ET/1:30 p.m. PT 
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Provides Executive Leadership Update
June 13, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports First Quarter 2025 Financial Results and Provides Business Update
May 08, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Participate in Upcoming Healthcare Conferences
May 06, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
April 17, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Provides Executive Leadership Update
March 28, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 26, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Participate in Upcoming Healthcare Conferences
February 25, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call
February 19, 2025
Call Scheduled for Wednesday, February 26, 2025, at 4:30 p.m. ET/1:30 p.m. PT 
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025
January 13, 2025
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update
November 25, 2024
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital
November 14, 2024
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update
November 06, 2024
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
September 19, 2024
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Participate in Upcoming Healthcare Conferences
August 29, 2024
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Reports Second Quarter 2024 Financial Results and Provides Business Update
August 07, 2024
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Host Mid-Year Earnings Conference Call
July 31, 2024
Call Scheduled for Wednesday, August 7, 2024, at 4:30 p.m. ET/1:30 p.m. PT 
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®)
July 28, 2024
From Alector, Inc.
Via GlobeNewswire
News headline image
Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024
July 23, 2024
From Alector, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap